BridgeMD
Prevention study for Perinatal Depression
Official title Implementation of Prevention and Intervention of Maternal Perinatal Depression to Strengthen Maternal and Child Health
ClinicalTrials.gov ID: NCT04069091
What this study is testing
- What it's testing
- IMPRINT strengthens maternal and child health by screening, treating and preventing maternal perinatal depression, the most common complication of pregnancy and the child's first 1000 days. It is associated with poor pregnancy outcome and perinatal mortality and has adverse consequences on physical and mental development of the child.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- EPDS screen result of 10 or more
- Agreed to be invited for the intervention during the screening phase
You likely can't join if
- Active suicidality
- Presence of severe mental disorder
- Concurrent use of psychotropic medication / concurrently under psychosocial treatment for mental disorder
The study team makes the final eligibility decision.
Where it's taking place
- Helsinki, Uusimaa, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Helsinki, Uusimaa, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.